Accelerated Atherosclerosis in Patients with Immune Mediated Disorders as a Model to Investigate the Link between Inflammation and Cardiovascular Disease: From Basic Mechanisms to Clinical Application

Informazioni relative al progetto

IM Targeting CVD

ID dell’accordo di sovvenzione: 281164

Progetto chiuso

Data di avvio 1 Aprile 2012

Data di completamento 31 Marzo 2017

Finanziato da

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 1 499 731,00

Contributo UE € 1 499 731,00

Coordinato da

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom